search
Back to results

SILS™ Port Laparoscopic Cholecystectomy Post Market Study

Primary Purpose

Gallbladder Disease

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
SILS™ port laparoscopic cholecystectomy
Four Port Laparoscopic Cholecystectomy
Sponsored by
Medtronic - MITG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gallbladder Disease focused on measuring Laparoscopic Cholecystectomy, Single Incision Laparoscopic Surgery, Surgical Procedures, Minimally Invasive

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Between 18 and 85 years old.
  • Patient has a diagnosis of biliary colic with documented gallstones or polyps by imaging or Biliary dyskinesia with documented EF < 30%.
  • Body Mass Index (BMI) < 45 kg/m2.

Exclusion Criteria:

  • Any female patient, who is pregnant, suspected pregnant, or nursing.
  • Any patient with acute calculus or acalculous cholecystitis.
  • Any patient who has had an upper midline or right sub costal incision.
  • Any patient with pre-operative indication for a cholangiogram.
  • Any patient with ASA > 3 with normal liver function.
  • Any patient who is undergoing Peritoneal Dialysis (PD).
  • Any patient who has an unrepaired umbilical hernia or has had prior umbilical hernia repair.

Sites / Locations

  • Yale New Haven Medical Center
  • Tampa General Hospital
  • Northwestern Memorial Hospital
  • Tufts Medical Center
  • North Shore - Long Island Jewish Health System
  • St. Francis Hospital
  • Case Medical Center
  • UT Southwestern Medical Center
  • Catholic University of Sacred Heart
  • Imperial College, England, St. Mary's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

SILS Port

Four Port

Arm Description

SILS™ Port Laparoscopic Cholecystectomy

Four Port Laparoscopic Cholecystectomy

Outcomes

Primary Outcome Measures

Feasibility and Safety of SILS™ Port Cholecystectomy Versus 4PLC
Feasibility and safety as determined by intraoperative and postoperative adverse events.
Operative Time
Duration of surgical procedure in minutes.
Estimated Blood Loss
Blood loss from surgical procedure in cc.

Secondary Outcome Measures

Average Pain Experienced in the Last 24 Hours at Various Time Frames
Pain evaluation as determined by a 10-point pain intensity numerical rating scale (PI-NRS) ranging from 0 (no pain) to 10 (worst possible pain).
Body Image Scale
The Body Image Scale consists of Questions 1-5 on the Body Image Questionnaire. Here, subjects were asked to answer each question on a scale from 1 to 4 with 1 being the best. Therefore, a total score of 5-20 was calculated for each patient with 5 being the best.
Cosmetic Scale
The Cosmetic Scale consists of Questions 6-8 on the Body Image Questionnaire. Here, patients were asked to answer questions regarding the cosmesis of their own scar (SILS™) or scars (4PLC). The first 2 questions were answered on a scale from 1 to 7 and Question 8 from 1 to 10, both with 1 being the worst. Therefore, a total score of 3-24 was calculated for each patient with 3 being the worst.
Confidence Scale Change From Baseline
The Confidence Scale consists of Questions 9 and 10 on the Body Image Questionnaire. One question is before procedure and another is after procedure. The Patients were asked to rate their overall confidence before (baseline) and after the procedure. The scores for before/after procedure range from 1 to 10 with 1 being "not very confident" and 10 being "very confident". The score difference from the before/after treatment is compared between the two procedures (4PLC and SILS™) Here, a positive score indicates that patient confidence has increased.
Normalized Scar Scores
Photo Series Questionnaire (PSQ). All subjects were asked to score their own scar (Question 1), then rate 2 standardized photos (one of 4PLC scars and one of a SILS™ scar) (Questions 2 and 3, respectively) and finally rate their own scar again after viewing the photos (Question 4). All scars were rated on a scale from 1 to 10 with 10 being the best. Normalized scores were analyzed for the photo questionnaire. In order to calculate the normalized score, each patient's score of the 4PLC photo was subtracted from their score of their own scar before viewing the photos. the median values were then used to calculate statistical significance. Normalized Scores of Own Scar are reported below: Question 1 - Question 2 (Q1 - Q2) Question 4 - Question 2 (Q4 - Q2) In order to calculate the normalized score for the subject's own scar, Q2 was used as baseline score since Q2 was the score for the conventional procedure 4PLC.
Modified Hollander
Surgeons were asked to answer 6 questions regarding the appearance of their subjects' scars. Each patient's score was summed for a total score 0 to 6 with 0 being the best.
Physical Quality of Life
SF8 questionnaire was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components. The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.
Mental Quality of Life
SF8 scale was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components. The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.
Time to Cannulization
Time required to insert SILS port system or 4 individual ports was captured for each procedure in minutes.

Full Information

First Posted
January 29, 2009
Last Updated
May 22, 2017
Sponsor
Medtronic - MITG
search

1. Study Identification

Unique Protocol Identification Number
NCT00832767
Brief Title
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Official Title
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
January 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic - MITG

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objectives of this trial are: to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SILS™ Port Laparoscopic Cholecystectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gallbladder Disease
Keywords
Laparoscopic Cholecystectomy, Single Incision Laparoscopic Surgery, Surgical Procedures, Minimally Invasive

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
202 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SILS Port
Arm Type
Active Comparator
Arm Description
SILS™ Port Laparoscopic Cholecystectomy
Arm Title
Four Port
Arm Type
Active Comparator
Arm Description
Four Port Laparoscopic Cholecystectomy
Intervention Type
Procedure
Intervention Name(s)
SILS™ port laparoscopic cholecystectomy
Intervention Description
This interventional arm will have a single incision laparoscopic cholecystectomy procedure.
Intervention Type
Procedure
Intervention Name(s)
Four Port Laparoscopic Cholecystectomy
Intervention Description
This interventional arm will have a traditional four port laparoscopic cholecystectomy procedure.
Primary Outcome Measure Information:
Title
Feasibility and Safety of SILS™ Port Cholecystectomy Versus 4PLC
Description
Feasibility and safety as determined by intraoperative and postoperative adverse events.
Time Frame
One year
Title
Operative Time
Description
Duration of surgical procedure in minutes.
Time Frame
Day 0
Title
Estimated Blood Loss
Description
Blood loss from surgical procedure in cc.
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Average Pain Experienced in the Last 24 Hours at Various Time Frames
Description
Pain evaluation as determined by a 10-point pain intensity numerical rating scale (PI-NRS) ranging from 0 (no pain) to 10 (worst possible pain).
Time Frame
Various (Pre-operative, Day 0, 1,3, 5, 1 Week, 2 Week and 1 Month)
Title
Body Image Scale
Description
The Body Image Scale consists of Questions 1-5 on the Body Image Questionnaire. Here, subjects were asked to answer each question on a scale from 1 to 4 with 1 being the best. Therefore, a total score of 5-20 was calculated for each patient with 5 being the best.
Time Frame
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Title
Cosmetic Scale
Description
The Cosmetic Scale consists of Questions 6-8 on the Body Image Questionnaire. Here, patients were asked to answer questions regarding the cosmesis of their own scar (SILS™) or scars (4PLC). The first 2 questions were answered on a scale from 1 to 7 and Question 8 from 1 to 10, both with 1 being the worst. Therefore, a total score of 3-24 was calculated for each patient with 3 being the worst.
Time Frame
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Title
Confidence Scale Change From Baseline
Description
The Confidence Scale consists of Questions 9 and 10 on the Body Image Questionnaire. One question is before procedure and another is after procedure. The Patients were asked to rate their overall confidence before (baseline) and after the procedure. The scores for before/after procedure range from 1 to 10 with 1 being "not very confident" and 10 being "very confident". The score difference from the before/after treatment is compared between the two procedures (4PLC and SILS™) Here, a positive score indicates that patient confidence has increased.
Time Frame
Change from Baseline (Pre-Op) at 1 Week, 2 Week, 1 Month, 3 Month and 1 Year
Title
Normalized Scar Scores
Description
Photo Series Questionnaire (PSQ). All subjects were asked to score their own scar (Question 1), then rate 2 standardized photos (one of 4PLC scars and one of a SILS™ scar) (Questions 2 and 3, respectively) and finally rate their own scar again after viewing the photos (Question 4). All scars were rated on a scale from 1 to 10 with 10 being the best. Normalized scores were analyzed for the photo questionnaire. In order to calculate the normalized score, each patient's score of the 4PLC photo was subtracted from their score of their own scar before viewing the photos. the median values were then used to calculate statistical significance. Normalized Scores of Own Scar are reported below: Question 1 - Question 2 (Q1 - Q2) Question 4 - Question 2 (Q4 - Q2) In order to calculate the normalized score for the subject's own scar, Q2 was used as baseline score since Q2 was the score for the conventional procedure 4PLC.
Time Frame
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Title
Modified Hollander
Description
Surgeons were asked to answer 6 questions regarding the appearance of their subjects' scars. Each patient's score was summed for a total score 0 to 6 with 0 being the best.
Time Frame
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Title
Physical Quality of Life
Description
SF8 questionnaire was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components. The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.
Time Frame
Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)
Title
Mental Quality of Life
Description
SF8 scale was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components. The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.
Time Frame
Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)
Title
Time to Cannulization
Description
Time required to insert SILS port system or 4 individual ports was captured for each procedure in minutes.
Time Frame
Day 0

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between 18 and 85 years old. Patient has a diagnosis of biliary colic with documented gallstones or polyps by imaging or Biliary dyskinesia with documented EF < 30%. Body Mass Index (BMI) < 45 kg/m2. Exclusion Criteria: Any female patient, who is pregnant, suspected pregnant, or nursing. Any patient with acute calculus or acalculous cholecystitis. Any patient who has had an upper midline or right sub costal incision. Any patient with pre-operative indication for a cholangiogram. Any patient with ASA > 3 with normal liver function. Any patient who is undergoing Peritoneal Dialysis (PD). Any patient who has an unrepaired umbilical hernia or has had prior umbilical hernia repair.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey Marks, MD
Organizational Affiliation
Case Medical Center University Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale New Haven Medical Center
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06510
Country
United States
Facility Name
Tampa General Hospital
City
Tampa
State/Province
Florida
ZIP/Postal Code
33601
Country
United States
Facility Name
Northwestern Memorial Hospital
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Facility Name
Tufts Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02111
Country
United States
Facility Name
North Shore - Long Island Jewish Health System
City
Lake Success
State/Province
New York
ZIP/Postal Code
11042
Country
United States
Facility Name
St. Francis Hospital
City
Roslyn
State/Province
New York
ZIP/Postal Code
11576
Country
United States
Facility Name
Case Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Facility Name
UT Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-8819
Country
United States
Facility Name
Catholic University of Sacred Heart
City
Rome
Country
Italy
Facility Name
Imperial College, England, St. Mary's Hospital
City
London
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
22549370
Citation
Solomon D, Shariff AH, Silasi DA, Duffy AJ, Bell RL, Roberts KE. Transvaginal cholecystectomy versus single-incision laparoscopic cholecystectomy versus four-port laparoscopic cholecystectomy: a prospective cohort study. Surg Endosc. 2012 Oct;26(10):2823-7. doi: 10.1007/s00464-012-2253-0. Epub 2012 May 2.
Results Reference
derived

Learn more about this trial

SILS™ Port Laparoscopic Cholecystectomy Post Market Study

We'll reach out to this number within 24 hrs